BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1581897)

  • 1. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
    Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
    Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liarozole potentiates the all-trans-retinoic acid-induced structural remodelling in human breast carcinoma MCF-7 cells in vitro.
    Van heusden J; Borgers M; Ramaekers F; Xhonneux B; Wouters W; De Coster R; Smets G
    Eur J Cell Biol; 1996 Sep; 71(1):89-98. PubMed ID: 8884182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
    Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.
    Van heusden J; Wouters W; Ramaekers FC; Krekels MD; Dillen L; Borgers M; Smets G
    Br J Cancer; 1998 Apr; 77(8):1229-35. PubMed ID: 9579827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo.
    Koshiuka K; Elstner E; Williamson E; Said JW; Tada Y; Koeffler HP
    Br J Cancer; 2000 Jan; 82(2):452-8. PubMed ID: 10646904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
    Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wołczyński S; Anchim T; Dziecioł J; Dabrowska M; Pietruczuk M
    Pol J Pathol; 2002; 53(2):59-65. PubMed ID: 12140868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
    Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
    J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of action.
    Bild T; Jose J; Hartmann RW
    Arch Pharm (Weinheim); 2004 Dec; 337(12):687-94. PubMed ID: 15597402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 2002 Feb; 178(3):186-94. PubMed ID: 11858735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
    Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
    Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
    Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
    Chen AC; Guo X; Derguini F; Gudas LJ
    Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of retinoids to human breast cancer cell lines and their effects on cell growth.
    Lacroix A; Lippman ME
    J Clin Invest; 1980 Mar; 65(3):586-91. PubMed ID: 7188772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
    Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
    J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.